
HHS
US cabinet health department; expanded Ebola entry ban to green-card holders on 8 June 2026 with no permanent CDC Director.
Last refreshed: 9 June 2026 · Appears in 1 active topic
Can HHS run a PHEIC response with an acting CDC Director, no permanent FDA Commissioner, and an urologist as Assistant Secretary for Health?
Timeline for HHS
Mentioned in: US renews 30-day Ebola entry ban
Pandemics and BiosecurityMaintained entry ban on DRC, Uganda and South Sudan nationals approaching 17 June expiry without announcing resolution
Pandemics and Biosecurity: US Ebola entry ban nears expiryExpanded 30-day Ebola entry ban to cover green-card holders (lawful permanent residents)
Pandemics and Biosecurity: US widens Ebola ban to green-card holdersThinnest US health bench faces PHEIC
Pandemics and BiosecurityWho is in charge of the US government's response to the Ebola outbreak?
What agencies does HHS oversee?
How does the current HHS leadership compare to the 2018 Ebola response?
Background
The US Department of Health and Human Services (HHS) is the cabinet-level federal department responsible for the country's public health infrastructure. Its principal sub-agencies include the CDC (Centers for Disease Control and Prevention), NIH (National Institutes of Health), FDA (Food and Drug Administration), ASPR (Administration for Strategic Preparedness and Response), and BARDA (Biomedical Advanced Research and Development Authority). HHS's combined budget is approximately $1.8 trillion annually, though biosecurity and preparedness programmes represent a small fraction of that.
In the context of the Bundibugyo PHEIC declared 17 May 2026, HHS has presented a markedly thin senior leadership bench. The position of Assistant Secretary for Health is occupied by Brian Christine, an Alabama urologist Senate-confirmed in October 2025. Jay Bhattacharya, confirmed as NIH Director in March 2025, concurrently holds the acting CDC Director role. No permanent FDA Commissioner, no permanent ASPR head, and no permanent CDC Director are in post. When CDC ran the 2018 Equateur response, all three positions were confirmed simultaneously .
On 8 June 2026, HHS expanded the 30-day Ebola entry ban (in force since 18 May) to include green-card holders (lawful permanent residents), with the order running to approximately 17 June . DRC's health minister called the restriction discriminatory and unsupported by Science; Kinshasa is negotiating an early lift. The WHO's IHR Emergency Committee has rejected travel bans as epidemiologically unjustified in this outbreak. No named deployed CDC personnel appear in WHO AFRO's coordination release for the Bundibugyo response; acting CDC Director Bhattacharya stated CDC has country offices in DRC and Uganda but the response structure does not cite specific US technical leads. The combination of leadership gaps, USAID dismantlement, and an acting CDC Director operating outside his professional domain defines what this briefing characterises as the weakest federal public-health roster of the post-2014 era. The entry ban expansion carries electoral significance ahead of the 2026 US midterms: the vaccine and outbreak-response politics of HHS under the current administration are a live partisan fault line.